[Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)].;Samenvatting van de multidisciplinaire richtlijn 'Cardiovasculair risicomanagement' (herziening 2011).

Nederlands tijdschrift voor geneeskunde

Volumn 156, Issue 36, 2012, Pages

  Wiersma, Tjerk ^a   Smulders, Yvo M ^b   Stehouwer, Coen D A ^b   Konings, Karin T S ^b   Lanphen, Joke ^b  

^a DUTCH COLLEGE OF GENERAL PRACTITIONERS   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CARDIOVASCULAR AGENT;

CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; HYPERTENSION; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; HYPOLIPIDEMIC AGENTS; NETHERLANDS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 84868611188     PISSN: None     EISSN: 18768784     Source Type: Journal    
DOI: None     Document Type: Review

References (0)